Weber – who was briefly chief operating officer of Takeda before rising to the CEO role and was the first non-Japanese person to lead the 243-year-old company – will be replaced by Julie Kim ...

Takeda has bolstered its near-term pipeline in rare haematological disorders by licensing rights to a polycythaemia vera (PV) treatment being developed by Protagonist Therapeutics. The Japanese ...

World leaders had hoped to secure U.S. backing for tougher sanctions on Russia, which struck Ukraine with a barrage of missiles and drones overnight. Trump Called Canada the 51st State. Now the G ...

She also writes the All Things with Kim Strassel newsletter and hosts the associated podcast. Ms. Strassel joined Dow Jones & Co. in 1994, working in the news department of The Wall Street Journal ...